Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment

被引：0
|
作者：
S. G. Simonson
P. D. Martin
P. Mitchell
D. W. Schneck
K. C. Lasseter
M. J. Warwick
机构：
[1] R&D Lund,AstraZeneca
[2] Experimental Medicine,AstraZeneca
来源：
European Journal of Clinical Pharmacology | 2003年 / 58卷
关键词：
Rosuvastatin; HMG-CoA reductase inhibitors; Hepatic impairment; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：669 / 675
页数：6
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment
    Simonson, SG
    Martin, PD
    Mitchell, P
    Schneck, DW
    Lasseter, KC
    Warwick, MJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (10) : 669 - 675
  • [2] Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment
    Charles E. Frost
    Van Ly
    Samira M. Garonzik
    [J]. Drugs in R&D, 2021, 21 : 375 - 384
  • [3] Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment
    Frost, Charles E.
    Ly, Van
    Garonzik, Samira M.
    [J]. DRUGS IN R&D, 2021, 21 (04) : 375 - 384
  • [4] Pharmacokinetics and pharmacodynamics of rosuvastatin in hepatically impaired subjects.
    Simonson, SG
    Martin, PD
    Mitchell, PD
    Schneck, DW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P86 - P86
  • [5] Pharmacokinetics of escitalopram in subjects with hepatic impairment
    Areberg, J
    Christophersen, JS
    Poulsen, MN
    Larsen, F
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 406 - 406
  • [6] Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment
    Marzin, Kristell
    Kretschmar, Gunther
    Luedtke, Doreen
    Kraemer, Sandrine
    Kuelzer, Raimund
    Schlenker-Herceg, Rozsa
    Schmid, Ulrike
    Schnell, David
    Dallinger, Claudia
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 357 - 363
  • [7] Pharmacokinetics Of Nintedanib In Subjects With Hepatic Impairment
    Marzin, K.
    Kretschmar, G.
    Schlenker-Herceg, R.
    Dallinger, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Pharmacokinetics of nelfinavir in subjects with hepatic impairment
    Damle, Bharat
    Hewlett, Dial, Jr.
    Hsyu, Poe-Hirr
    Becker, Mark
    Petersen, Annkatrin
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1241 - 1249
  • [9] Pharmacokinetics of Ribociclib in Subjects With Hepatic Impairment
    Samant, Tanay S.
    Yang, Shu
    Miller, Michelle
    Ji, Yan
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (08): : 1001 - 1009
  • [10] Pharmacokinetics of linagliptin in subjects with hepatic impairment
    Graefe-Mody, Ulrike
    Rose, Peter
    Retlich, Silke
    Ring, Arne
    Waldhauser, Lisa
    Cinca, Rodica
    Woerle, Hans-Juergen
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 75 - 85
12345